Skip to main contentBack to Top

The Center's research efforts focus on two main areas:

First, discovery and validation of biomarkers for disease prediction and diagnosis, secondly, pharmacomics and drug discovery for personalized medicine.

Established in the summer of 2002, the Center for Biotechnology and Genomic Medicine (CBGM) at the Medical College of Georgia (MCG) at Augusta University (AU) was developed to promote interdisciplinary and translational research in Biotechnology and Genomic Medicine with the ultimate goal of promoting predictive, preventive, personalized and participatory (4P) medicine.

The Center's research efforts focus on two main areas: 1) discovery and validation of biomarkers for disease prediction and diagnosis, 2) pharmacomics and drug discovery for personalized medicine.  CBGM is home of four internationally renowned programs in diabetes research: The Environmental Determinants of Diabetes in the Young (TEDDY), the Prospective Assessment in Newborns of Diabetes Autoimmunity (PANDA), the Diabetic Complications Consortium (DiaComp) and the Mouse Metabolic Phenotype Consortium (MMPC). Additional research programs include autoimmune diseases, transplantation, and cancer. These research programs are supported by an annual extramural funding of approximately $12 million.

The center houses several state-of-the-art high throughput and high content facilities for genetics, genomics, proteomics, drug screening and bioinformatics. The center continues to recruit independent investigators with expertise in diverse disciplines such as genomics, proteomics, immunology, medicinal chemistry, drug development, biostatistics and computational biology. This multidisciplinary approach provides an avenue for investigators to interact and stimulate novel ideas.

 screenshot of Paul's Diabetes app

Most risk calculators for diabetic microvascular complications are limited to research labs because of how complicated the statistical analysis is. This calculator was developed to fill the gap and allow individuals to estimate their own specific risk.

Please click on the image of the calculator to be taken to the website.

THE INFORMATION PROVIDED BY THIS TOOL IS NOT MEDICAL ADVICE AND CANNOT BE USED TO DIAGNOSE OR TREAT ANY MEDICAL CONDITION. We do not retain any information that you provide in connection with your use of the tool.


CBGM logo






Contact Us

Medical College of Georgia

Health Sciences Campus

Interdisciplinary Research Center

Sarah Gross
Office Specialist : 706-721-3410
Debbie Ellison
Dept. Admin. : 706-721-3433

1462 Laney Walker Blvd. Augusta, GA 30912

8 a.m. - 5 p.m.





Three people, two men and a woman, stand in a lab looking at the camera

McIndoe to lead $6.2 million innovative research initiative

Dr. Richard A. McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia, is leading a $6.2 million federally funded initiative to support highly innovative research ideas in three areas with tremendous impact on health.

Doctors in lab

New approach emerges to better classify, treat brain tumors

A new method that produces a better tumor profile is particularly adept at recognizing some of the most serious gliomas, the most common brain tumor type in adults.

Doctors in a lab

Cervical cancer survival may improve by targeting senescent ‘zombie’ cells

How well women with cervical cancer respond to treatment and survive correlates with the level of 10 proteins in their blood that also are associated with a “zombie” cell state called senescence, Medical College of Georgia scientists report.

Doctors in lab

Antibodies against sugars, internal radiation: powerful package against cervical cancer

The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy.

More News for CBGM